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a b s t r a c t
This study describes the isolation and characterisation of adult canine cardiac stem cells, and explores
their ability to differentiate into cardiac myocytes. Direct comparisons are also made with available
human data. Atrial cardiac explants were taken from dogs post-mortem and cultured to isolate adult
stem cells. Cells were able to survive successive passages in serum-free media, were able to form cardi-
ospheres, and under controlled culture conditions were capable of clonal expansion, demonstrating their
ability for self-renewal. Characterisation of these cells demonstrated the following marker proﬁle: c-kit,
GATA 4 and ﬂk-1 positive; cardiac troponin T and NKx2.5 low. Cardiac lineage directed differentiation
was performed based on the published literature. Gene expression studies demonstrated that cardiac
directed differentiation was partially achieved, with up-regulation of cardiac troponin T and NKx2.5,
and down-regulation of c-kit and endothelial lineage markers. However the cells did not express the
ryanodine receptor or b1-adrenergic receptors and did not contract spontaneously.
 2011 Elsevier Ltd. All rights reserved.
Introduction
Recently the heart has been shown to possess a natural popula-
tion of stem-like cells (Anversa and Kajstura, 1998; Beltrami et al.,
2001; Nadal-Ginard et al., 2003). Messina et al. (2004) identiﬁed
and characterised a cell population from both the mouse and hu-
man heart with properties of adult cardiac stem cells (CSCs). The
isolated cells grew as self-adherent clusters, which they termed
‘cardiospheres’. These cells were capable of self-renewal and in
the case of murine cells could spontaneously differentiate
in vitro and in vivo into cardiomyocytes, endothelial cells and
smooth muscle cells. The human cells were also shown to differen-
tiate but only following co-culture with rat neonatal cardiomyo-
cytes (Messina et al., 2004). Other studies have also shown
evidence for cardiac self-renewal; Bergmann et al. (2009) used
radio-carbon dating and ageing cardiac cells from human surgical
patients, identifying cells that had originated post-partum.
Although the majority of experimental evidence clearly shows
that adult stem cells (ASCs) are present in the heart, our knowledge
of these cells in terms of their characteristics and marker expres-
sion is limited and the conditions that drive their differentiation
are unclear. The variety of species studied, the variation in meth-
ods used and the range of markers examined are all confounding
factors. Several studies have shown that cells from experimental
animal models such as mice appear to differentiate spontaneously
using specialised differentiation media. Conversely, experiments
using porcine tissue or human tissue, which are often reliant upon
biopsy specimens from patients with cardiac disease, appear to re-
quire co-culture with other cell types such as the rat neonatal car-
diomyocyte (Beltrami et al., 2003; Messina et al., 2004; Smith et al.,
2007).
Further confounding the ﬁeld, and in contrast to previous stud-
ies, Andersen et al. (2009) have recently questioned the ability to
isolate adult CSCs frommurine and rat tissues. Interestingly, in this
particular study, neonatal tissues were utilised and spontaneous
beating was seen in some of the explants in culture. Furthermore
protocols for isolation of CSCs were adapted from standard tech-
niques. This highlights the difﬁculty in drawing inferences from
published literature and identiﬁes the requirement for studies in
the speciﬁc species of interest.
In dogs, cardiac disease causes signiﬁcant morbidity and mor-
tality, contributing to over 50% of mortalities in some breeds such
as the Cavalier King Charles spaniel (Bonnett et al., 2005). Typically
the dog is predisposed to either endocardiosis or dilated cardiomy-
opathy. Although an increasing number of treatment modalities
are available these are all entirely supportive and not curative.
Evaluation of the possibilities for regenerative medicine in the
treatment of cardiac disease requires characterisation of the
endogenous stem cell population. In addition the stem cells may
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play a role in disease pathogenesis in conditions such as cardiomy-
opathy. Although two studies have looked speciﬁcally at canine
CSCs (Bartosh et al., 2008; Linke et al., 2005), they provide limited
information in terms of characterisation or requirements for
differentiation.
The present project aimed to address three speciﬁc and funda-
mental questions: (1) Can adult CSCs be derived from the canine
heart? (2) How do these cells compare with stem cells from other
species in terms of behaviour in culture and expression of mark-
ers? and (3) Can these cells undergo cardiac directed
differentiation?
Materials and methods
Tissue preparation and isolation of cardiac stem cells
Full thickness canine cardiac tissue was harvested from the right and left atria
and ventricles immediately post-mortem. Dogs were euthanased for clinical rea-
sons and tissues harvested with owner consent.
The tissue was dissected and digested with 0.2% trypsin (Invitrogen) and 0.1%
collagenase IV (Invitrogen). Explants were placed into ﬁbronectin (Costar) coated
T25 ﬂasks with complete explant medium (CEM) which comprised Iscove’s Modi-
ﬁed Dulbecco’s Medium (IMDM; Invitrogen) with 10% fetal calf serum (Invitrogen),
100 U/mL penicillin G and 100 lg/mL streptomycin (both Invitrogen), 2 mmol/L
L-glutamine (Gibco), 0.1 mmol/L 2-mercaptoethanol (2-ME; Sigma) and were main-
tained at 37 C in 5% CO2.
Explants adhered to the ﬂasks generating a ﬁbroblast-like layer with phase-
bright (PB) non-adherent cells ﬂoating above. Cells (5  104) were seeded onto
24-well plates in 600 lL basic cardiosphere growing serum-free media: 35% IMDM;
65% Dulbecco’s Modiﬁed Eagle’s Medium (DMEM) – Ham F-12 mix (Invitrogen)
with 2% 50X B27 (Invitrogen); 50 mM 2-ME; 10 ng/mL epidermal growth factor
(EGF, Peprotech); 20 ng/mL basic ﬁbroblast growth factor (bFGF, Peprotech);
40 nmol/L cardiotrophin-1 (Invitrogen); 40 nmol/L bovine thrombin (Sigma);
100 U/mL penicillin G; 100 lg/mL streptomycin; 2 mmol/L L-glutamine. Cardiotro-
phin (2.5 ng/mL), EGF (1.5 ng/mL) and bFGF (1.5 ng/mL) were added every 2–
3 days.
Clonal expansion analysis
Plates (48-well) coated with 0.1% gelatin type A (Sigma) were seeded with
1  104 cells/well in 500 lL of cardiosphere media. Individual cells adherent to
the gelatin were visible 12 h later. Plates were incubated at 37 C in 5% CO2. Cells
were fed every 2 days by half media changes. After 6 days in culture large spheres
could be seen arising from the individual cells, indicating clonal expansion.
RNA extraction and RT-PCR analysis
Total RNA from stem cells and control tissues was isolated using the RNeasy
Mini Kit (Qiagen), cleaned up using RNase-free DNase kit (Qiagen), and quantiﬁed
using the Thermo Scientiﬁc Nanodrop (Thermo Scientiﬁc).
For semi-quantitative RT-PCR, RNA was reverse-transcribed using the Omni-
script Reverse Transcription kit (Qiagen). PCR was performed using GoTaq PCR Core
Systems kit (Promega). Primer pairs were designed based on published canine se-
quences (NCBI) and the Primer3 software1 (Table 1). NKx2.5 primers were taken
from Vaags et al. (2009). GAPDH was multiplexed creating an internal positive con-
trol. Bands of corresponding sizes were sequenced and compared to the canine gen-
ome (NCBI).
For quantitative RT-PCR RNA was reverse-transcribed using Transcriptor High
Fidelity cDNA Synthesis kit (Roche). Reactions were run using the Lightcycler 480
Probes Master kit. Data were normalised to 18s RNA (Applied Biosystems). A stan-
dard PCR was also performed using individual primers and products run on a 3%
agarose gel to conﬁrm speciﬁcity of primers.
Immunoﬂuorescence analysis
Cardiosphere cultures were incubated with rabbit polyclonal anti-c-kit anti-
body (Dako, Cat No. A4502; dilution: 1:100) previously validated in the dog (Morini
et al., 2004), and an anti-ﬂk-1 antibody (Abcam, Ab2349; dilution: 1:100). Second-
ary Alexaﬂuor 488 conjugated goat polyclonal anti-rabbit IgG (Invitrogen) diluted
at 1:500 was used. Nuclear counterstaining was performed using DAPI mount
(Vectastain).
Differentiation of cardiac stem cells
CSCs/well (2  104) were placed into a 48-well plate with 0.1% gelatin coating.
Four differentiation protocols were followed in triplicate following 5 days of stem
cell colony establishment. Protocols 1 and 2 were based on Smits et al. (2009)
and Protocols 3 and 4 followed Oh et al. (2003). Triplicates of control CSCs main-
tained in cardiosphere media were run concurrently. Individual protocols were ini-
tiated as follows:
Protocol 1: Cells were placed in differentiation media for 24 h (235 mL of IMDM
and 235 mL of Ham’s F12 nutrient mixture with GlutaMAX-I, 10 mL fetal calf serum,
1 (5 mL) MEM non-essential amino acids, 1 (5 mL) insulin-transferrin). This was
followed by 3 days in differentiation media plus 5 lM 50Azacytidine (50 AZA Sigma).
Then, the cells were returned into standard differentiation media, refreshed every
2 days with 1 ascorbic acid (Sigma) and 1 ng/mL of TGF-b (Peprotech) every
4 days.
Protocol 2: As above but excluding addition of TGF-b.
Protocol 3: Cells were cultured in M199 media (Invitrogen) plus 10% fetal calf
serum. Media was replaced daily for 3 days and then removed and replaced with
M199 media plus 2% fetal calf serum with 3 lM 50AZA. This media was replaced
every 3 days.
Protocol 4: As for protocol 3 excluding addition of 50AZA.
All protocols were continued for 22 days.
Results
Cardiac stem cell culture
CSCs were cultured from a total of 25 dogs. Cardiac explants
grew an adherent ﬁbroblast layer overlaid with spherical PB cells
either singly or in grape-like clusters (Fig. 1A and B). Subjectively,
atrial explants consistently produced more PB cells compared to
the ventricles and were therefore used for all data in this study.
1 http://primer3.sourceforge.net/.
Table 1
Primer pairs designed for marker expression proﬁles, including markers for stem cells,
cardiac lineage stem cells and differentiated cells. CTT, cardiac troponin T; beta 1 ad,
b1-adrenergic receptor; cardiac RyR, cardiac ryanodine receptor; CTI, cardiac troponin
I; VEGF, vascular endothelial growth factor; VWF, von Willebrand factor; SMA,
smooth muscle actin.
Marker Sequence 50–30 Predicted
product size
C-kit F: ATA TCC CAA ACC GGA GCA C 193
R: TCA CCG AAG AAT TGA CAT CG
Islet 1 F: GGT TTC TCC GGA TTT GGA AT 183
R: CAC GAA GTC GTT CTT GCT GA
NKx2.5 F: CCA AGG ACC CTC GAG CTG A 185
R: CGA CAG ATA CCG CTG CTG CT
GATA 4 F: CAA GAT GAA TGG CAT CAA CC 216
R: GGT TTG AAT CCC CTC TTT CC
Flk 1 F: CCA CCC AGA CTC AGC ATA CA 188
R: CAC TTT TGG AAT CGT GAG CA
CTT F: GAA GGA CCT GAA CGA ACT 210
R: CCT CCT GTT CTC CTC CTC CT
Beta 1 ad F: GAG TAC GGC TCC TTC CTG TG 274
R: AGC ACT TGG GGT CGT TGT AG
Cardiac RyR F: AAG CGA AGC AGC CCA AGG GT 888
R: TCA GCA AAG TGT GCC GCG CT
CTI F: TCT GCG CAT GGC GGA TGA GA 624
R: TTG CGG CCC TCC ATT CCA CT
VEGF F: TTC CTG CAG CAT AGC AAA TG 293 (239,311)
R: AGG GAG GCT CCT TCT TCC AG
VWF F: CTG GGA GAA GAG AGT CAC GG 235
R: GTG GAT GGA GTA CAC GGC TT
SMA F: GGG GAT GGG ACA AAA GGA CA 525
R: GCC ACG TAG CAG AGC TTC TCC TTG A
Glomulin F: TTG AAG AGC CCT CTG GAA AA 131
R: ACT CCA AAG GGT GGA CAA TG
GAPDH F: CAT CAA CGG GAA GTC CAT CT 428
R: GTG GAA GCA GGG ATG ATG TT
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CSCs were placed into serum-free media and over 2–3 weeks
formed cardiospheres, which continued to increase in size and
number, and could be harvested and passaged (Fig. 1C and D).
When CSCs were plated at low density, clonal expansion was
demonstrated. Single cells adhered to gelatin within 12 h (Fig. 2A
and B) and developed large spherical colonies over 5–7 days
Fig. 1. In vitro culture of cardiac stem cells (CSCs). Large spherical, phase-bright cells migrated from the explant overlying a ﬁbroblast-like adherent layer (A), magniﬁcation
200. These cells were loosely attached to the ﬁbroblast-like layer or free ﬂoating (B), magniﬁcation 400. These cells resembled cardiospheres as previously described (C),
magniﬁcation 100, and (D), magniﬁcation 200.
Fig. 2. Clonal expansion. Cardiac stem cells were plated at low density to allow visualisation of single cells (A and B), magniﬁcation 200. Large spheres grew out from the
individual cells indicating clonal expansion (C and D), magniﬁcation 200.
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indicative of clonal expansion (Fig. 2C and D). These spheres could
be passaged, creating more spheres. At passage, a large central cell
could be seen, surrounded by cells of varying sizes, suggestive of
asymmetric division. CSCs plated as single cells did not survive cul-
ture suggesting that the CSCs required the presence of other CSCs
to trigger survival.
Cardiac stem cell analysis
CSC populations were characterised using RT-PCR for the fol-
lowing markers (Table 1); stem cell markers (c-kit and islet 1)
(Beltrami et al., 2003; Cai et al., 2003; Goumans et al., 2007; Kubo
et al., 2008; Laugwitz et al., 2005; Moretti et al., 2006; Tallini et al.,
2009), early cardiac differentiation markers (NKx2.5, GATA 4 and
ﬂk-1) (Beltrami et al., 2003; Goumans et al., 2007; Laugwitz
et al., 2005; Lints et al., 1993; Matsuura et al., 2004; Wu et al.,
2006), cardiomyocyte markers (cardiac troponin T [CTT], b1 adren-
ergic receptor [Beta 1 Ad], ryanodine receptor [RyR], and cardiac
troponin I [CTI]), endothelial cell markers (vascular endothelial
growth factor [VEGF] and von Willebrand’s Factor [vWF]), and
smooth muscle markers (smooth muscle actin [SMA] and
glomulin).
Fig. 3. Characterisation of cardiac stem cells (CSC). (A) RT-PCR analysis of CSC expression following extended culture in cardiosphere media. Two representative dogs are
shown (A and B labelled beneath); culture in serum-free media in days labelled above. (B) CSCs express c-kit and ﬂk-1 (dogs C–E), magniﬁcation 400. Greyscale images show
cell morphology. (C) Fully developed cardiospheres express c-kit (magniﬁcations 100, 200, 400; top, central and bottom rows, respectively). DAPI was used to
counterstain nuclei (greyscale images from the central column). Negative controls were performed by labelling with secondary antibody only.
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Marker expression proﬁles of CSCs were analysed over a 15-day
time course. Markers were compared to whole heart tissue, with
GAPDH as a multiplexed positive control (Fig. 3A). C-kit was ex-
pressed in all canine CSCs with some variation in levels between
dogs and a lower level expression was detected in whole heart. Is-
let 1 expression was not detected. Flk-1 expression was detected at
all time points with a lower expression in whole heart. Both
NKx2.5 and CTT were expressed strongly only in whole heart.
GATA 4 was clearly expressed in all cell samples and whole heart.
The patterns of expression showed little variation over the 15 days.
Using IFA CSCs stained positively for c-kit (cell surface and cyto-
plasmic distribution) and ﬂk-1 (nuclear distribution) (Fig. 3B).
Differentiation of cardiac stem cells towards cardiac lineages
CSCs were exposed to four differentiation protocols (Fig. 4). A
control culture of stem cells maintained in stem cell media was
run concurrently, which formed cardiospheres. At 12 h all wells
looked morphologically similar (Fig. 5A), with individual stem cells
adhering to the gelatin layer. The cells began to form a conﬂuent
adherent layer 3 days after protocol initiation, whereas control
cells in cardiosphere media formed individual adherent spheres.
Morphologically cells exposed to differentiation protocols (proto-
cols 1 and 3) appeared to line up, unlike the cells exposed to the
modiﬁed protocols aimed at limited or no differentiation (proto-
cols 2 and 4). After 3 weeks, the control stem cell line was still
forming spheres.
Gene expression proﬁles for each protocol were analysed and
compared to a standard CSCs and whole heart expression pattern.
CSCs following protocols 1 and 2 appeared to have similar expres-
sion patterns to each other: low c-kit, NKx2.5, vWF, and CTT; no
expression of islet 1, CTI, RyR and Beta 1 Ad expression, and a rel-
atively high GATA 4, ﬂk-1, VEGF, SMA and glomulin expression.
Those following protocols 3 and 4 demonstrated differences in
expression. When protocols 3 and 4 were compared to the stan-
dard controls (Fig. 5C; dogs D and E), (1) c-kit and vWF were
down-regulated in protocol 3 compared to protocol 4; (2) NKx2.5
appeared up-regulated in protocol 3 compared to protocol 4; (3)
Fig. 4. Differentiation of cardiac stem cells. Four protocols were designed: 1 and 2
were based on Smits et al. (2009), 3 and 4 on Oh et al. (2003); these included the
standard and a modiﬁed differentiation protocol adapted from each.
Fig. 5. Analysis of cardiac stem cell differentiation. (A) Time course of morphological changes upon induced cardiac differentiation (protocols 1–4); a control culture of stem
cells maintained in serum free culture conditions (CSC) (magniﬁcation 200). (B and C) RT-PCR of control culture (CSC), whole heart tissue (WHT) and stem cells after 22 days
of cardiac differentiation. (B) Stem cells extracted from dog E under each protocol (1–4). (C) Stem cells from dogs D and E under differentiation protocols 3 and 4. Markers
were designed to analyse cardiac development lineage and endothelial, smooth muscle, and functional cardiomyocyte lineage as indicated in the text.
Fig. 6. Relative expression changes following cardiac stem cell differentiation. Quantitative RT-PCR for NKx2.5 and GATA 4 and cardiac troponin T (CTT) of stem cells from
dogs D and E differentiated under protocols (Pr) 3 and 4. Results were standardised to 18s ribosomal RNA controls and compared to expression levels from whole heart.
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GATA 4 expression remained high following both protocols; (4) no
islet 1 expression was seen; (5) ﬂk-1, VEGF, smooth muscle actin
and glomulin expression remained at high levels across both pro-
tocols; (6) CTT expression was up-regulated following protocol 3
with a larger increase seen in dog E compared to dog D cells. In
all four protocols, there was no expression of the cardiac functional
protein genes CTI, RyR and Beta 1 Ad.
Quantitative analysis of NKx2.5, GATA 4 and CTT expression
was examined compared to whole heart tissue expression. A 3.4-
and 5.1-fold (dogs D and E, respectively) up-regulation in NKx2.5
expression was observed in the cells under protocol 3 compared
to protocol 4. However, GATA 4 appeared unchanged between
the two protocols. CTT had an approximate 1.5-fold up-regulation
in dog D and a 3.3-fold up-regulation in dog E (Fig. 6) using proto-
col 3 compared to protocol 4.
Discussion
In this study, we have isolated cells from the canine heart,
which demonstrate phenotypic and genotypic characteristics con-
sistent with ASCs. The culture techniques proved reliable in repro-
ducing directly comparative cardiosphere populations from
multiple dogs of different ages and sex and these cardiospheres be-
haved similarly to those described for other species (Messina et al.,
2004; Smith et al., 2007). Canine CSCs could be grown in serum
free conditions, a standard technique for CSCs (Messina et al.,
2004). In addition, cells were capable of clonal expansion, a critical
characteristic of stem cells.
Canine CSCs expressed key markers consistent with CSCs and
did not express cardiac structural and functional proteins. C-kit
was expressed at CSC harvest and at the cardiosphere stage
and was demonstrated at both the transcriptional and transla-
tional levels. C-kit is an accepted CSC marker and has been used
in other species, in particular humans. C-kit positive stem cells
have been found to be able to differentiate into cardiomyocytes
(Beltrami et al., 2003; Goumans et al., 2007; Kubo et al., 2008;
Tallini et al., 2009). C-kit in combination with NKx2.5 has been
used to deﬁne a CSC population able to differentiate into cardio-
myocytes and smooth muscle (Lints et al., 1993; Wu et al.,
2006).
Flk-1 was expressed at both the RNA and protein levels with the
protein in a nuclear location, indicating an active form. Flk-1 has
been shown to be expressed in some, but not all CSC populations.
Bearzi et al. (2007) described a human CSC population positive for
c-kit and negative for ﬂk-1. The same author also described a c-kit
positive, ﬂk-1 positive population which behaved as a coronary
vascular progenitor cell (Bearzi et al., 2009). Yang et al. (2008) iso-
lated ﬂk-1 positive, c-kit negative stem cell populations from the
human heart which gave rise to colonies which contained all three
cardiac lineages. This interesting variation in c-kit and ﬂk-1
expression may represent a heterogeneous stem cell population
or different developmental stages.
GATA 4 expression was seen in both CSCs and whole heart, as
previously described (Goumans et al., 2007). GATA 4, an early tran-
scription factor expressed in the developing heart, is expressed
abundantly in CSCs and cardiac myocytes during their lifespan
and is thought to be cardioprotective, preventing post-infarction
remodelling (Beltrami et al., 2007; Goumans et al., 2007; Heikinheimo
et al., 1994; Laugwitz et al., 2005; Matsuura et al., 2004; Rysa et al.,
2010). NKx2.5, an early expressed homeobox gene, was expressed
in whole heart tissue but not in the canine CSCs (Martin et al.,
2004). NKx2.5 has commonly but not exclusively been found to
be expressed in CSCs (Beltrami et al., 2003; Goumans et al.,
2007; Laugwitz et al., 2005; Oh et al., 2003). Canine CSCs were po-
sitive for the endothelial marker vWF, an important ﬁnding in CSCs
and one not described in other tissue speciﬁc ASC populations (Hu
et al., 2003; Kattman et al., 2006; Welikson et al., 2007).
Finally, in agreement with CSC populations isolated from other
species (Bearzi et al., 2007; Beltrami et al., 2003; Goumans et al.,
2007; Oh et al., 2003), our cell population was lineage negative
with no expression of the cardiac functional genes CTI, RyR and
Beta 1 Ad.
CSC differentiation has been described using a variety of culture
techniques and pharmacological interventions (Behfar et al., 2002;
Goumans et al., 2007; Messina et al., 2004; Oh et al., 2003; Smits
et al., 2009; Tallini et al., 2009). We selected two published tech-
niques and designed standard and modiﬁed differentiation proto-
cols based upon them (Oh et al., 2003; Smits et al., 2009).
Following the differentiation protocols (1 and 3) the cells appeared
to be more organised when compared to the modiﬁed protocols (2
and 4). This alignment may represent development of an organised
cell–cell contact, suggesting a more deﬁnitive phenotype.
Protocols 1 and 2 showed little difference in expression pat-
terns, but altered expression from CSCs: c-kit and vWF expression
was lost and low levels of CTT and NKx2.5 were seen. Protocols 3
and 4 had more striking results which may suggest that 50AZA is
a critical factor. Following protocol 3, there was loss of expression
of c-kit and vWF like in protocols 1 and 2. There was also high
expression of NKx2.5 and CTT. This suggests that this protocol
was most efﬁcient at driving the CSCs toward a cardiac lineage.
Cells following protocol 4 expressed CTT at a lower level and did
not lose c-kit and vWF expression or exhibit NKx2.5 expression.
No variation in GATA 4 expression was seen in all differentiation
protocols, suggesting that its expression is a requirement for these
cells during the differentiation process.
SMA and glomulin were highly expressed in the CSCs and may
therefore be constitutively expressed. This suggests predetermined
smooth muscle differentiation capabilities, which are not affected
by the protocols used.
Conclusions
The canine heart has a reliable and reproducible resident popu-
lation of adult stem cells. These cells compare favourably with
other CSCs and in particular human CSCs. While some degree of
differentiation occurred with protocol 3, complete differentiation
was not achieved. Cells did not spontaneously contract and expres-
sion of key components of the contractile machinery was not de-
tected. Nevertheless this study provides a comprehensive
characterisation of canine CSCs and is the basis for further study
aiming to optimise the conditions required for differentiation.
Conﬂict of interest statement
None of the authors of this paper has a ﬁnancial or personal
relationship with other people of organisations that could inappro-
priately inﬂuence or bias the content of this paper.
Acknowledgments
We thank D. Clements for his technical advice and support and
R. Muirhead for assistance with laboratory work. This work was
generously funded by the RCVS Charitable Trust Golden Jubilee
Award.
References
Andersen, D.C., Andersen, P., Schneider, M., Jensen, H.B., Sheikh, S.P., 2009. Murine
‘‘cardiospheres’’ are not a source of stem cells with cardiomyogenic potential.
Stem cells 27, 1571–1581.
H.M. Hodgkiss-Geere et al. / The Veterinary Journal 191 (2012) 176–182 181
Anversa, P., Kajstura, J., 1998. Ventricular myocytes are not terminally differentiated
in the adult mammalian heart. Circulation Research 83, 1–14.
Bartosh, T.J., Wang, Z., Rosales, A.A., Dimitrijevich, S.D., Roque, R.S., 2008. 3D-model
of adult cardiac stem cells promotes cardiac differentiation and resistance to
oxidative stress. Journal of Cellular Biochemistry 105, 612–623.
Bearzi, C., Rota, M., Hosoda, T., Tillmanns, J., Nascimbene, A., De Angelis, A.,
Yasuzawa-Amano, S., Troﬁmova, I., Siggins, R.W., Lecapitaine, N., Cascapera, S.,
Beltrami, A.P., D’Alessandro, D.A., Zias, E., Quaini, F., Urbanek, K., Michler, R.E.,
Bolli, R., Kajstura, J., Leri, A., Anversa, P., 2007. Human cardiac stem cells.
Proceedings of the National Academy of Sciences United States of America 104,
14068–14073.
Bearzi, C., Leri, A., Lo Monaco, F., Rota, M., Gonzalez, A., Hosoda, T., Pepe, M., Qanud,
K., Ojaimi, C., Bardelli, S., D’Amario, D., D’Alessandro, D.A., Michler, R.E.,
Dimmeler, S., Zeiher, A.M., Urbanek, K., Hintze, T.H., Kajstura, J., Anversa, P.,
2009. Identiﬁcation of a coronary vascular progenitor cell in the human heart.
Proceedings of the National Academy of Sciences United States of America 106,
15885–15890.
Behfar, A., Zingman, L.V., Hodgson, D.M., Rauzier, J.M., Kane, G.C., Terzic, A., Puceat,
M., 2002. Stem cell differentiation requires a paracrine pathway in the heart.
The FASEB Journal 16, 1558–1566.
Beltrami, A.P., Urbanek, K., Kajstura, J., Yan, S.M., Finato, N., Bussani, R., Nadal-
Ginard, B., Silvestri, F., Leri, A., Beltrami, C.A., Anversa, P., 2001. Evidence that
human cardiac myocytes divide after myocardial infarction. The New England
Journal of Medicine 344, 1750–1757.
Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., Kasahara,
H., Rota, M., Musso, E., Urbanek, K., Leri, A., Kajstura, J., Nadal-Ginard, B.,
Anversa, P., 2003. Adult cardiac stem cells are multipotent and support
myocardial regeneration. Cell 114, 763–776.
Beltrami, A.P., Cesselli, D., Bergamin, N., Marcon, P., Rigo, S., Puppato, E., D’Aurizio,
F., Verardo, R., Piazza, S., Pignatelli, A., Poz, A., Baccarani, U., Damiani, D., Fanin,
R., Mariuzzi, L., Finato, N., Masolini, P., Burelli, S., Belluzzi, O., Schneider, C.,
Beltrami, C.A., 2007. Multipotent cells can be generated in vitro from several
adult human organs (heart, liver, and bone marrow). Blood 110, 3438–3446.
Bergmann, O., Bhardwaj, R.D., Bernard, S., Zdunek, S., Barnabe-Heider, F., Walsh, S.,
Zupicich, J., Alkass, K., Buchholz, B.A., Druid, H., Jovinge, S., Frisen, J., 2009.
Evidence for cardiomyocyte renewal in humans. Science 324, 98–102.
Bonnett, B.N., Egenvall, A., Hedhammar, A., Olson, P., 2005. Mortality in over 350,
000 insured Swedish dogs from 1995–2000: I. Breed-, gender-, age- and cause-
speciﬁc rates. Acta Veterinaria Scandinavica 46, 105–120.
Cai, C.L., Liang, X., Shi, Y., Chu, P.H., Pfaff, S.L., Chen, J., Evans, S., 2003. Isl1 identiﬁes a
cardiac progenitor population that proliferates prior to differentiation and
contributes a majority of cells to the heart. Development Cell 5, 877–889.
Goumans, M.J., de Boer, T.P., Smits, A.M., van Laake, L.W., van Vliet, P., Metz, C.H.,
Korfage, T.H., Kats, K.P., Hochstenbach, R., Pasterkamp, G., Verhaar, M.C., van der
Heyden, M.A., de Kleijn, D., Mummery, C.L., van Veen, T.A., Sluijter, J.P.,
Doevendans, P.A., 2007. TGF-beta1 induces efﬁcient differentiation of human
cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem
Cell Research 1, 138–149.
Heikinheimo, M., Scandrett, J.M., Wilson, D.B., 1994. Localization of transcription
factor GATA-4 to regions of the mouse embryo involved in cardiac
development. Developmental Biology 164, 361–373.
Hu, Y., Liao, L., Wang, Q., Ma, L., Ma, G., Jiang, X., Zhao, R.C., 2003. Isolation and
identiﬁcation of mesenchymal stem cells from human fetal pancreas. Journal of
Laboratory and Clinical Medicine 141, 342–349.
Kattman, S.J., Huber, T.L., Keller, G.M., 2006. Multipotent ﬂk-1+ cardiovascular
progenitor cells give rise to the cardiomyocyte, endothelial, and vascular
smooth muscle lineages. Development Cell 11, 723–732.
Kubo, H., Jaleel, N., Kumarapeli, A., Berretta, R.M., Bratinov, G., Shan, X., Wang, H.,
Houser, S.R., Margulies, K.B., 2008. Increased cardiac myocyte progenitors in
failing human hearts. Circulation 118, 649–657.
Laugwitz, K.L., Moretti, A., Lam, J., Gruber, P., Chen, Y., Woodard, S., Lin, L.Z., Cai, C.L.,
Lu, M.M., Reth, M., Platoshyn, O., Yuan, J.X., Evans, S., Chien, K.R., 2005. Postnatal
isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433,
647–653.
Linke, A., Muller, P., Nurzynska, D., Casarsa, C., Torella, D., Nascimbene, A., Castaldo,
C., Cascapera, S., Bohm, M., Quaini, F., Urbanek, K., Leri, A., Hintze, T.H., Kajstura,
J., Anversa, P., 2005. Stem cells in the dog heart are self-renewing, clonogenic,
and multipotent and regenerate infarcted myocardium, improving cardiac
function. Proceedings of the National Academy of Sciences United States of
America 102, 8966–8971.
Lints, T.J., Parsons, L.M., Hartley, L., Lyons, I., Harvey, R.P., 1993. Nkx-2.5: a novel
murine homeobox gene expressed in early heart progenitor cells and their
myogenic descendants. Development 119, 969.
Martin, C.M., Meeson, A.P., Robertson, S.M., Hawke, T.J., Richardson, J.A., Bates, S.,
Goetsch, S.C., Gallardo, T.D., Garry, D.J., 2004. Persistent expression of the ATP-
binding cassette transporter, Abcg2, identiﬁes cardiac SP cells in the developing
and adult heart. Developmental Biology 265, 262–275.
Matsuura, K., Nagai, T., Nishigaki, N., Oyama, T., Nishi, J., Wada, H., Sano, M., Toko,
H., Akazawa, H., Sato, T., Nakaya, H., Kasanuki, H., Komuro, I., 2004. Adult
cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. Journal of
Biological Chemistry 279, 11384–11391.
Messina, E., De Angelis, L., Frati, G., Morrone, S., Chimenti, S., Fiordaliso, F., Salio, M.,
Battaglia, M., Latronico, M.V.G., Coletta, M., Vivarelli, E., Frati, L., Cossu, G.,
Giacomello, A., 2004. Isolation and expansion of adult cardiac stem cells from
human and murine heart. Circulation Research 95, 911–921.
Moretti, A., Caron, L., Nakano, A., Lam, J.T., Bernshausen, A., Chen, Y., Qyang, Y., Bu, L.,
Sasaki, M., Martin-Puig, S., Sun, Y., Evans, S.M., Laugwitz, K.L., Chien, K.R., 2006.
Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle,
and endothelial cell diversiﬁcation. Cell 127, 1151–1165.
Morini, M., Bettini, G., Preziosi, R., Mandrioli, L., 2004. C-kit gene product (CD117)
immunoreactivity in canine and feline parafﬁn sections. Journal of
Histochemistry and Cytochemistry 52, 705–708.
Nadal-Ginard, B., Kajstura, J., Leri, A., Anversa, P., 2003. Myocyte death, growth, and
regeneration in cardiac hypertrophy and failure. Circulation Research 92, 139–
150.
Oh, H., Bradfute, S.B., Gallardo, T.D., Nakamura, T., Gaussin, V., Mishina, Y., Pocius, J.,
Michael, L.H., Behringer, R.R., Garry, D.J., Entman, M.L., Schneider, M.D., 2003.
Cardiac progenitor cells from adult myocardium: homing, differentiation, and
fusion after infarction. Proceedings of the National Academy of Sciences United
States of America 100, 12313–12318.
Rysa, J., Tenhunen, O., Serpi, R., Soini, Y., Nemer, M., Leskinen, H., Ruskoaho, H., 2010.
GATA-4 is an angiogenic survival factor of the infarcted heart. Circulation: Heart
Failure 3, 440–450.
Smith, R.R., Barile, L., Cho, H.C., Leppo, M.K., Hare, J.M., Messina, E., Giacomello, A.,
Abraham, M.R., Marban, E., 2007. Regenerative potential of cardiosphere-
derived cells expanded from percutaneous endomyocardial biopsy specimens.
Circulation 115, 896–908.
Smits, A.M., van Vliet, P., Metz, C.H., Korfage, T., Sluijter, J.P., Doevendans, P.A.,
Goumans, M.J., 2009. Human cardiomyocyte progenitor cells differentiate into
functional mature cardiomyocytes: an in vitro model for studying human
cardiac physiology and pathophysiology. Nature Protocols 4, 232–243.
Tallini, Y.N., Greene, K.S., Craven, M., Spealman, A., Breitbach, M., Smith, J., Fisher,
P.J., Steffey, M., Hesse, M., Doran, R.M., Woods, A., Singh, B., Yen, A.,
Fleischmann, B.K., Kotlikoff, M.I., 2009. C-kit expression identiﬁes
cardiovascular precursors in the neonatal heart. Proceedings of the National
Academy of Sciences United States of America 106, 1808–1813.
Vaags, A.K., Rosic-Kablar, S., Gartley, C.J., Zheng, Y.Z., Chesney, A., Villagomez, D.A.,
Kruth, S.A., Hough, M.R., 2009. Derivation and characterization of canine
embryonic stem cell lines with in vitro and in vivo differentiation potential.
Stem Cells 27, 324–340.
Welikson, R.E., Kaestner, S., Evans, A.M., Hauschka, S.D., 2007. Embryonic
cardiomyocyte expression of endothelial genes. Developmental Dynamics
236, 2512–2522.
Wu, S.M., Fujiwara, Y., Cibulsky, S.M., Clapham, D.E., Lien, C.L., Schultheiss, T.M.,
Orkin, S.H., 2006. Developmental origin of a bipotential myocardial and smooth
muscle cell precursor in the mammalian heart. Cell 127, 1137–1150.
Yang, L., Soonpaa, M.H., Adler, E.D., Roepke, T.K., Kattman, S.J., Kennedy, M.,
Henckaerts, E., Bonham, K., Abbott, G.W., Linden, R.M., Field, L.J., Keller, G.M.,
2008. Human cardiovascular progenitor cells develop from a KDR+ embryonic-
stem-cell-derived population. Nature 453, 524–528.
182 H.M. Hodgkiss-Geere et al. / The Veterinary Journal 191 (2012) 176–182
